[go: up one dir, main page]

AU6914998A - Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties - Google Patents

Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties

Info

Publication number
AU6914998A
AU6914998A AU69149/98A AU6914998A AU6914998A AU 6914998 A AU6914998 A AU 6914998A AU 69149/98 A AU69149/98 A AU 69149/98A AU 6914998 A AU6914998 A AU 6914998A AU 6914998 A AU6914998 A AU 6914998A
Authority
AU
Australia
Prior art keywords
active agent
surface active
formulation containing
pharmacokinetic properties
ionic surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69149/98A
Inventor
Hugh W. Price
B. Michael R. Woloski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cangene Corp
Original Assignee
Cangene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cangene Corp filed Critical Cangene Corp
Publication of AU6914998A publication Critical patent/AU6914998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU69149/98A 1997-04-07 1998-04-07 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties Abandoned AU6914998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4192197P 1997-04-07 1997-04-07
US60041921 1997-04-07
PCT/CA1998/000325 WO1998044948A2 (en) 1997-04-07 1998-04-07 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties

Publications (1)

Publication Number Publication Date
AU6914998A true AU6914998A (en) 1998-10-30

Family

ID=21919058

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69149/98A Abandoned AU6914998A (en) 1997-04-07 1998-04-07 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties

Country Status (3)

Country Link
EP (1) EP0973549A2 (en)
AU (1) AU6914998A (en)
WO (1) WO1998044948A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914801B1 (en) * 2002-03-21 2011-03-29 The United States Of America As Represented By The Secretary Of Agriculture Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MY150740A (en) 2002-10-24 2014-02-28 Abbvie Biotechnology Ltd Low dose methods for treating disorders in which tnf? activity is detrimental
FR2853551B1 (en) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM
CN101679507A (en) 2007-03-29 2010-03-24 艾博特公司 crystalline anti-human il-12 antibodies
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
FR2961107B1 (en) * 2010-06-15 2012-07-27 Lab Francais Du Fractionnement HUMAN IMMUNOGLOBULIN COMPOSITION STABILIZED

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064396A (en) 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
JP2547556B2 (en) * 1987-02-06 1996-10-23 株式会社 ミドリ十字 Liquid formulation of r-globulin
ATE65410T1 (en) * 1987-11-27 1991-08-15 Akzo Nv STABILIZATION OF ANTIBODIES.
JPH0778025B2 (en) 1990-03-20 1995-08-23 日本赤十字社 Method for producing immunoglobulin G
AU7345094A (en) * 1993-07-01 1995-01-24 Unilever Plc Oral compositions
FR2708467B1 (en) 1993-07-30 1995-10-20 Pasteur Merieux Serums Vacc Stabilized immunoglobulin preparations and process for their preparation.
CA2151409C (en) * 1995-05-05 2000-08-15 Juan Carlos Rodriguez Formulation for stabilizing human immunoglobulins
US6686191B1 (en) * 1995-09-22 2004-02-03 Bayer Healthcare Llc Preparation of virally inactivated intravenously injectable immune serum globulin

Also Published As

Publication number Publication date
WO1998044948A2 (en) 1998-10-15
WO1998044948B1 (en) 1999-04-01
WO1998044948A3 (en) 1999-02-11
EP0973549A2 (en) 2000-01-26

Similar Documents

Publication Publication Date Title
AU3068599A (en) Medication infusion set
GB9401857D0 (en) Intravenous infusion set
ZA962248B (en) Nanususpensions for intravenous administration
HK1108658A1 (en) An intravenous catheter
AU4132793A (en) Infusion packets
AU7348198A (en) Absorbent article having position retaining element
EP0971758A4 (en) Intravenous infusion system
HUP0103852A3 (en) Container for intravenous administration
HK1032010A1 (en) Medicament formulation with a controlled release of an active agent.
AU7836794A (en) New cytotoxic agents
AU4757093A (en) Antinephrotic syndrome agent
AU695171B2 (en) Enrofloxacine injection or infusion solutions
AU6914998A (en) Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
AU8136198A (en) A head-mounted carrier for positioning opto-electronic devices in front of the user's eyes
USD410081S (en) Medication infusion device
AU3477399A (en) Structured surface articles containing geometric structures with compound faces and methods for making same
USD406201S (en) Mobile workstation
GB9412140D0 (en) Non-ionic surface active compounds
USD365191S (en) Infusion package
AU3924193A (en) Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
AU7768694A (en) Infusion package
USD364492S (en) Infusion package
PL347770A1 (en) Composition for the parenteral administration of active agents
USD368966S (en) Telephone monitored medication dispenser
USD383931S (en) Chair arm